Compare Lululemon Athletica Inc (LULU) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lululemon Athletica Inc vs Tempus AI — how do they compare? Lululemon Athletica Inc trades at $94.5 (market cap $10.27B), while Tempus AI trades at $70.93 (market cap $12.58B). The key difference: Tempus AI is the larger of the two by market cap, and Tempus AI is trading nearer its 52-week high, Lululemon Athletica Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Lululemon Athletica Inc for 105 Days and Tempus AI for 23 Days on average.
| LULU | TEM | |
|---|---|---|
Market Cap | $10.27B | $12.58B |
Volume | 4,392,324 | 7,444,569 |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $215.88 | $96.39 |
52-Week Low | $91.88 | $41.55 |
Typical Hold Time | 105 Days | 23 Days |
Enterprise Value | $11.02B | $13.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lululemon stock trades at $92.68, down 54% year-to-date and near 52-week lows. The company reported strong Q2 2026 earnings with EPS of $2.92 beating expectations of $1.79, but faces growth concerns with revenue declining year-over-year. Technical indicators show bearish momentum with the stock trading below key resistance levels, while valuation metrics appear attractive with P/E of 7.63 and P/S of 0.97.
Despite attractive valuations and strong profitability metrics (ROE 30.9%, net margin 12.78%), Lululemon faces significant headwinds including growth stagnation, multiple securities fraud investigations, and competitive pressures. The stock presents a high-risk opportunity with potential for recovery if management can address operational challenges and restore investor confidence.
Tempus AI (TEM) trades at $69.28, down 1.44% today, with a bullish technical signal despite bearish moving averages. The company shows strong revenue growth (2026: $1.4B) but remains unprofitable with negative margins. Recent FDA clearance for ECG-MR AI product and ESMO Congress presentations highlight innovation momentum. Analyst consensus is strongly bullish with 64% buy ratings and $72.60 price target.
TEM offers growth potential in AI-driven healthcare diagnostics but carries significant execution risk due to persistent losses. The stock's high P/S ratio (8.61) reflects growth expectations, yet negative ROE (-67.44%) and insider selling warrant caution. Upside depends on profitability improvements and commercial adoption of new AI products.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lululemon Athletica Inc
Lululemon Athletica Inc. designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 600 company-owned stores in 18 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.
Read more on LULU →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
